These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31100255)

  • 41. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30: Radical Prostatectomy Versus Radiation for Clinically Localized Prostate Cancer: Two Systematic Reviews and a Randomized Controlled Trial.
    Lazar AA; Lizarraga TLC; Roach M
    Eur Urol; 2016 Jul; 70(1):e13-e14. PubMed ID: 26935558
    [No Abstract]   [Full Text] [Related]  

  • 42. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
    Liauw SL; Weichselbaum RR; Zagaja GP; Jani AB
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1316-21. PubMed ID: 18234446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.
    Catton C; Gospodarowicz M; Warde P; Panzarella T; Catton P; McLean M; Milosevic M
    Radiother Oncol; 2001 Apr; 59(1):51-60. PubMed ID: 11295206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant radiotherapy use and patterns of care analysis for margin-positive prostate adenocarcinoma with extracapsular extension: postprostatectomy adjuvant radiotherapy: a SEER analysis.
    Ghia AJ; Shrieve DC; Tward JD
    Urology; 2010 Nov; 76(5):1169-74. PubMed ID: 20709371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized Trial.
    Fiorentino A; Errico A; Scarcia M
    Eur Urol; 2019 Apr; 75(4):e93-e94. PubMed ID: 30502105
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.
    Tsien C; Griffith KA; Sandler HM; McLaughlin P; Sanda MG; Montie J; Reddy S; Hayman JA
    Urology; 2003 Jul; 62(1):93-8. PubMed ID: 12837430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival.
    Abugharib A; Jackson WC; Tumati V; Dess RT; Lee JY; Zhao SG; Soliman M; Zumsteg ZS; Mehra R; Feng FY; Morgan TM; Desai N; Spratt DE
    J Urol; 2017 Mar; 197(3 Pt 1):662-668. PubMed ID: 27614333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months.
    De E; Pisters LL; Pettaway CA; Scott S; Westney OL
    J Urol; 2007 Jun; 177(6):2200-4; discussion 2204. PubMed ID: 17509319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant radiation treatment after prostatectomy. Where do we stand?
    Elshaikh MA; Ibrahim DR; Stricker H; Peabody JO
    Can J Urol; 2011 Apr; 18(2):5592-600. PubMed ID: 21504646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in the use of postprostatectomy therapies for patients with prostate cancer: a surveillance, epidemiology, and end results Medicare analysis.
    Sheets NC; Hendrix LH; Allen IM; Chen RC
    Cancer; 2013 Sep; 119(18):3295-301. PubMed ID: 23842985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. Eur urol 2014;66:1024-30.
    De Bari B; Alongi F; Arcangeli S
    Eur Urol; 2014 Dec; 66(6):e111-2. PubMed ID: 25190611
    [No Abstract]   [Full Text] [Related]  

  • 55. Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
    Pai HH; Eldridge B; Bishop D; Alexander A; Lesperance M; Blood P; Lim J; Ludgate C
    Can J Urol; 2009 Apr; 16(2):4541-52. PubMed ID: 19364426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment results of salvage radiotherapy for biochemical recurrence after radical prostatectomy].
    Hatano K; Kinouchi T; Kinoshita T; Kobayashi M; Inoue H; Takada T; Hara T
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):671-8. PubMed ID: 19999131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002.
    Ates F; Akyol I; Soydan H
    Eur Urol; 2012 Jul; 62(1):e9; author reply e10-1. PubMed ID: 22512903
    [No Abstract]   [Full Text] [Related]  

  • 58. Re: Christian Bolenz, Stephen J. Freedland, Brent K. Hollenbeck, et al. costs of radical prostatectomy for prostate cancer: a systematic review. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.059.
    Rassweiler J
    Eur Urol; 2013 Apr; 63(4):e53-6. PubMed ID: 23312570
    [No Abstract]   [Full Text] [Related]  

  • 59. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
    Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy.
    Lee LW; McBain CA; Swindell R; Wylie JP; Cowan RA; Logue JP
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):517-22. PubMed ID: 15630843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.